Orbsen Therapeutics
Orbsen Therapeutics is a Healthcare & Life Sciences startup based in Ireland, most recent round Pre-Seed, 1 tracked investor.
About Orbsen Therapeutics
Orbsen Therapeutics is a company headquartered in Ireland. Its most recent tracked round is Pre-Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Orbsen Therapeutics develops cell therapies based on mesenchymal stromal cells, targeting conditions such as diabetic foot ulcers, acute respiratory distress syndrome, diabetic kidney disease, and primary sclerosing cholangitis. The company is conducting clinical trials, including the NEPHSTROM study, to evaluate its ORBCEL™ cell therapy.
Explore Orbsen Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.